Himalaya Nutravedics FY26: revenue doubles to ₹4,306.8 lakhs, PAT up 231.1% as own-brand share reaches 51.1%

FY26 revenue up 105.1% to ₹4,306.8 lakhs, EBITDA up 171.0%, PAT up 231.1% to ₹739.0 lakhs.

Sat 3 Oct 2026

FY26 Revenue from Operations

rose 105.1% to ₹4,306.8 lakhs

FY26 EBITDA

rose 171.0% to ₹810.3 lakhs (margin 18.8%)

FY26 PAT

rose 231.1% to ₹739.0 lakhs

ROE / ROCE

ROE was 63.9% and ROCE 36.4%

EPS

fell to 18.3 from 24.8

📉 FY26 revenue from operations rose 105.1% to ₹4,306.8 lakhs, EBITDA rose 171.0% to ₹810.3 lakhs (margin 18.8%) and PAT rose 231.1% to ₹739.0 lakhs. ROE was 63.9% and ROCE 36.4%, but cash flow from operations was ₹-383.4 lakhs versus ₹-139.1 lakhs in FY25, and EPS fell to 18.3 from 24.8.

🏭 Own-brand business rose to 51.1% of revenue in FY26 from 19.7% in FY25, ayurvedic products made up 94.6% of revenue, and Kerala remained the anchor market at 49.3%. The company says medicated oil capacity utilisation reached 90.2% on a single-shift basis.

📌 Management states it plans to move from an exclusively B2B, practitioner-driven model to omni-channel, with a proprietary D2C platform, e-commerce and quick-commerce listings. It proposes to deploy ₹750.00 lakhs of net proceeds on branding and digital marketing.

🌍 The presentation also lists new SKUs in pain management, gut health, women's wellness and neurological support, deeper tier-2 and tier-3 distribution, and export registration capabilities. It cites herbal and vitamin market growth forecasts as support.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.